Cargando…
New Pathway for Cisplatin Prodrug to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic Resistance
[Image: see text] Tumor cells adapt to diverse survival strategies defying our pursuit of multimodal cancer therapy. Prostate cancer (PCa) is an example that is resistant to one of the most potent chemotherapeutics, cisplatin. PCa cells survive and proliferate using fatty acid oxidation (FAO), and t...
Autores principales: | Kalathil, Akil A., Guin, Subham, Ashokan, Akash, Basu, Uttara, Surnar, Bapurao, Delma, Katiana S., Lima, Leonor M., Kryvenko, Oleksandr N., Dhar, Shanta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375877/ https://www.ncbi.nlm.nih.gov/pubmed/37521786 http://dx.doi.org/10.1021/acscentsci.3c00286 |
Ejemplares similares
-
Correction to
“New Pathway for Cisplatin Prodrug
to Utilize Metabolic Substrate Preference to Overcome Cancer Intrinsic
Resistance”
por: Kalathil, Akil A., et al.
Publicado: (2023) -
Clinically Approved
Antiviral Drug in an Orally Administrable
Nanoparticle for COVID-19
por: Surnar, Bapurao, et al.
Publicado: (2020) -
Targeted Mitochondrial COQ(10) Delivery Attenuates
Antiretroviral-Drug-Induced Senescence of Neural Progenitor Cells
por: Velichkovska, Martina, et al.
Publicado: (2018) -
Transformation of Amphiphilic Antiviral Drugs into
New Dimensional Nanovesicles Structures
por: Hamdan, Suzana, et al.
Publicado: (2022) -
Histopathology and Ultrastructural Findings of Fatal COVID-19 Infections on Testis
por: Achua, Justin K., et al.
Publicado: (2021)